Medical Letter on the CDC and FDA

Angiogenesis - EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076

Atrophy - QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome

Attention Deficit Hyperactivity Disorder - FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients

Barr Pharmaceuticals, Inc. - Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base)

Biotechnology Business - Biotech has Positive Year Despite Weak Fourth Quarter Performance

Bipolar Disorder - AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

Bladder Cancer - Spectrum Pharmaceuticals Receives Scientific Advice from the EMEA on Registrational Strategy for EOquin(R) in Europe

Cancer Vaccines - Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma

Clinical Trial Research - ATryn(R) Nears Completion of US HD Clinical Study

Clinical Trial Research - Human Genome Sciences Announces 2008 Goals and Reports Substantial Progress Toward Commercialization at JPMorgan Healthcare Conference

Diabetes - Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza

Drug Development - TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders

Epilepsy - Orphan Drug Designation Granted to OVATION's Clobazam for the Adjunctive Treatment of a Severe Form of Childhood Epilepsy

Gene Therapy - NEOPHARM Announces IND Filing for Novel Liposomal Delivery System of Docetaxel

Heart Failure - Abiomed Announces AB5000(R) Portable Circulatory Support Driver

HIV/AIDS - Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports

Laser Systems - CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis

Life Sciences - BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

Mindray Medical International Limited - Mindray Medical Provides New Product Update

Myeloma - Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma

Nausea - Helsinn and MGI Pharma Announce sNDA for Aloxi Capsules Accepted for Review by U.S. FDA

Osiris Therapeutics - Osiris Therapeutics Awarded Department of Defense Contract for Prochymal(TM) Fully Valued at $224.7 Million

Pouchitis - Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis

Radiology - Penumbra, Inc. Announces 510(k) Clearance of the Penumbra System(TM) for Use in the Revascularization of Patients With Acute Ischemic Stroke

Regulatory Actions - BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study

Regulatory Actions - Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration

Regulatory Actions - Luminex Corporation Receives U.S. Food and Drug Administration Clearance for xTAG(TM) Respiratory Viral Panel

Research and Markets - The Most Recent Statistical Data On the Complexities of Disaster Preparedness Is Contained In Disaster Recovery Planning a Guide for Facility Managers 4th Edition

Sciele Pharma, Inc. - Sciele Pharma Announces FDA Approval of New Sular(R) Formulation

Seizure - Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate

Spinal Cord Injury - XenoPort Announces Initiation of Clinical Trials

The Neurologic & Orthopedic Hospital of Chicago - FDA Approves Hi-Flex Mobile Bearing Knee for Active Adults

Type 2 Diabetes - Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.

Ultrasound Systems - Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System

ViraCor Laboratories - ViraCor Laboratories Is First National Reference Laboratory To Offer Novel Respiratory Viral Testing